Roswell Park Comprehensive Cancer Center Chief of Colorectal Surgery Steven Nurkin, MD, MS, FACS, is slated to speak at the National Comprehensive Cancer Network (NCCN) 2023 Annual Conference, happening March 31-April 2 in Orlando.

Research conducted at Roswell Park Comprehensive Cancer Center shows that the types of T cells circulating in the blood of patients with recurrent ovarian cancer may predict the likelihood that their disease will respond to an anti-PD1 immunotherapy. The findings, which grew out of a phase 2 clinical trial led by Emese Zsiros, MD, PhD, FACOG, Chair and Director of Research, Department of Gynecologic Oncology, will be highlighted at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer, March 25-28 in Tampa, Florida.

Two Roswell Park Comprehensive Cancer Center faculty leaders will give invited talks during symposium sessions as the Society for Surgical Oncology (SSO) gathers this week for the 2023 International Conference on Surgical Cancer Care in Boston, Mass.